Chlorpheniramine Maleate / Codeine Suppliers & Bulk Manufacturers
Available Forms: Extended-Release Tablets
Available Strengths: 54.3 mg of codeine; 8 mg of chlorpheniramine maleate
Reference Brands: Tuzistra XR®, Tuxarin ER®(US); Corex®(India)
Category:
Respiratory Disorder
Chlorpheniramine Maleate + Codeine is a prescription combo used to treat cough and allergy symptoms. Available in the US as Tuzistra XR® and Tuxarin ER®, it combines antihistamine and cough suppressant effects. Ideal for regulated B2B, PCD, and pharma export targeting respiratory care.
Chlorpheniramine Maleate / Codeine is available in Extended-Release Tablets
and strengths such as 54.3 mg of codeine; 8 mg of chlorpheniramine maleate.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Chlorpheniramine Maleate / Codeine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Chlorpheniramine Maleate / Codeine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Chlorpheniramine Maleate + Codeine is a prescription combination medication used to treat cough, cold, and allergy symptoms. Chlorpheniramine acts as an antihistamine to reduce sneezing and runny nose, while codeine suppresses persistent cough. Available in the US under brands like Tuzistra XR® and Tuxarin ER®, it comes in extended-release tablets and oral solutions. Due to codeine’s opioid nature, it's classified as a Schedule III controlled substance, requiring careful prescribing. Although not widely available in the EU due to stricter opioid regulations, this combo remains in demand for B2B, PCD pharma, and regulated pharmaceutical export markets targeting respiratory relief.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing